Found 1 clinical trials
Expanded Access of Omidubicel for Allogeneic Transplantation in Patients With Hematological Malignancies
Omidubicel is an investigational therapy for patients with high-risk hematologic malignancies.
investigational treatment
allogeneic transplantation
cancer
hematologic malignancy
- 0 views
- 19 Feb, 2024